We are live on
!
Find out more
OLA
Oliver Luxxe Assets Portfolio holdings
AUM
$680M
1-Year Est. Return
47.51%
This Fund
S&P 500
This Quarter
Est. Return
+18.61%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$680M
AUM Growth
+$12.5M
(+1.9%)
Cap. Flow
-$82.1M
Cap. Flow
% of AUM
-12.07%
Top 10 Holdings %
Top 10 Hldgs %
19.1%
Holding
216
New
16
Increased
34
Reduced
132
Closed
17
Top Buys
| 1 |
AstraZeneca
AZN
|
+$8.52M |
| 2 |
NRG Energy
NRG
|
+$6.36M |
| 3 |
TD Synnex
SNX
|
+$5.16M |
| 4 |
Stryker
SYK
|
+$3.97M |
| 5 |
Deere & Co
DE
|
+$3.68M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
+$6.62M |
| 2 |
Salesforce
CRM
|
+$5.9M |
| 3 |
Estee Lauder
EL
|
+$5M |
| 4 |
Sanmina
SANM
|
+$3.63M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$3.59M |
Sector Composition
| 1 | Financials | 16.71% |
| 2 | Industrials | 16.07% |
| 3 | Technology | 15.33% |
| 4 | Healthcare | 10.36% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Costco
COST
$417B
| – | – |
-230
| Closed | -$229K |
|
|
202
Salesforce
CRM
$140B
| – | – |
-31,633
| Closed | -$5.9M |
|
203
Corteva
CTVA
$58.4B
| – | – |
-2,631
| Closed | -$220K |
|
|
204
Estee Lauder
EL
$29.7B
| – | – |
-69,636
| Closed | -$5M |
|
205
Flowserve
FLS
$8.75B
| – | – |
-23,028
| Closed | -$1.69M |
|
|
206
HCA Healthcare
HCA
$82.3B
| – | – |
-13,989
| Closed | -$6.62M |
|
207
Itron
ITRI
$3.81B
| – | – |
-24,836
| Closed | -$2.23M |
|
208
Leidos
LDOS
$13.4B
| – | – |
-15,905
| Closed | -$2.47M |
|
209
Lincoln National
LNC
$8.08B
| – | – |
-60,199
| Closed | -$2.14M |
|
210
Modine Manufacturing
MOD
$12.2B
| – | – |
-1,000
| Closed | -$217K |
|
211
Mettler-Toledo International
MTD
$26.5B
| – | – |
-200
| Closed | -$252K |
|
|
212
Regeneron Pharmaceuticals
REGN
$70.9B
| – | – |
-4,641
| Closed | -$3.59M |
|
213
Signet Jewelers
SIG
$3.56B
| – | – |
-26,159
| Closed | -$2.21M |
|
|
THR
214
DELISTED
Thermon Group Holdings
THR
| – | – |
-58,051
| Closed | -$2.93M |
|
215
State Street Energy Select Sector SPDR ETF
XLE
$38.2B
| – | – |
-3,795
| Closed | -$232K |
|
|
EXE
216
Expand Energy Corp
EXE
$21.1B
| – | – |
-3,255
| Closed | -$357K |
|
Similar funds
CCG
CIA
NS
WDL
HI
ISWM
TIP
AP
Oliver Luxxe Assets's Q2 2026 Portfolio in Review
As of Q2 2026, Oliver Luxxe Assets held 216 positions worth $680M, up 1.9% from $668M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Oliver Luxxe Assets withdrew a net $82.1M in Q2 2026, closing 17 positions and reducing 132 holdings. Its most notable exit was HCA Healthcare, an estimated $6.62M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.
Against the trend, Oliver Luxxe Assets opened a new position in AstraZeneca worth $8.52M.
- Oliver Luxxe Assets's largest Q2 2026 buy was AstraZeneca: 45,272 shares worth $8.52M.
- Oliver Luxxe Assets added most to TE Connectivity in Q2 2026, an estimated $2.72M increase.
- Oliver Luxxe Assets's biggest Q2 2026 reduction was Sanmina, cutting an estimated $3.63M.
- Oliver Luxxe Assets fully exited HCA Healthcare in Q2 2026, selling an estimated $6.62M.
- Oliver Luxxe Assets's ten largest holdings make up 19% of its $680M portfolio in Q2 2026.
- Oliver Luxxe Assets opened 16 new positions and closed 17 in Q2 2026.
- Oliver Luxxe Assets's portfolio value rose 1.9% quarter-over-quarter to $680M.
Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.